查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1629899

全球生物基包裝市場 - 2025-2033

Global Bio Based Packaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球生物基包裝市場將於 2024 年達到 19 億美元，預計到 2033 年將達到 40 億美元，在 2025-2033 年預測期間複合年成長率為 8.5%。

醫療保健生物基包裝是指專門為製藥、醫療器材和醫療保健行業設計的包裝解決方案，由可再生的生物來源材料製成，而不是傳統的塑膠或其他不可生物分解的材料。這些包裝解決方案的開發是為了滿足醫療保健行業的嚴格要求，例如無菌、屏障保護、耐用性和安全性，同時又環保。

隨著醫療保健公司和消費者認知到永續發展和減少包裝材料對環境影響的重要性，醫療保健產業對生物基包裝的需求一直在穩步成長。例如，根據英國製藥工業協會 (ABPI) 的數據，大約 70% 至 80% 的碳足跡來自製造過程，這些製造過程的設計者和發明者表示，所做的決定將與該產品一起持續存在。作為藥物的剩餘使用壽命。

市場動態：

驅動程式和限制

製藥公司不斷提高的永續發展目標

製藥公司不斷提高的永續發展目標正在顯著推動生物基包裝市場的成長，預計將在預測期內推動市場發展。主要製藥公司正在製定雄心勃勃的永續發展目標，例如透過使用生物基包裝材料將永續發展納入其企業策略來實現淨零排放或減少碳足跡來實現這些目標。

例如，2024 年 10 月，TekniPlex Healthcare 推出了首款經 ISCC PLUS 認證的生物基 PVC 化合物，為醫療包裝提供了永續的替代品。其新材料設計用於醫療包裝應用，如管材、托盤薄膜、袋子和其他塑膠零件，提供環保選擇。其化合物採用再生能源製成，可減少高達 90% 的二氧化碳排放，幫助醫療保健產業在不損失性能或安全性的情況下創造更永續的包裝。

FDA 和 EMA 等監管機構越來越重視減少醫療保健產業包裝材料對環境的影響。這些法規鼓勵採用永續實踐，包括透過 ISO 合規性等認證來使用生物基包裝材料。

例如，2024 年1 月，專業和永續材料解決方案和服務的領先供應商Avient Corporation 宣布將在Pharmapack 2024 上重點展示其生物基聚合物解決方案組合。添加劑以及生物基聚合物解決方案。

嚴格的監管要求

嚴格的監管要求造成了合規性複雜化、成本增加和市場採用受限等障礙，嚴重阻礙了生物基包裝市場的成長。由於藥品包裝的重要性，這些法規在醫療保健領域尤其嚴格。生物基包裝必須符合與傳統材料在製藥應用中的安全性、無菌性和功能性相同的嚴格標準。這包括嚴格的生物相容性測試、穩定性測試以及與包裝內藥物或醫療器材的兼容性。

例如，FDA 要求生物基包裝材料經過廣泛的測試，以證明它們不會與藥品或醫療設備等內容物產生負面交互作用。例如，材料不得浸出有害物質或損害藥物或設備的完整性。與傳統塑膠相比，這些要求使得生物基材料的監管過程更加複雜和耗時。

不同地區對生物基材料的監管要求差異很大，這給希望在全球銷售產品的公司帶來了挑戰。例如，與歐盟的 REACH（化學品註冊、評估、授權和限制）法規相比，美國 FDA 的法規有所不同。這些差異使生物基包裝製造商標準化其產品以適應國際市場的能力變得更加複雜。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按材料類型分類的片段
  • 按應用程式片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 製藥公司不斷提高的永續發展目標
    • 限制
      • 嚴格的監管要求
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：生物基包裝市場（依材料類型）

  • 生物分解塑膠
  • 可生物分解的紙和紙板
  • 可生物分解薄膜
  • 其他

第 6 章：生物基包裝市場（依應用）

  • 製藥及生物製藥業
  • 營養保健品公司
  • 個人護理和化妝品
  • 其他

第 7 章：生物基包裝市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 8 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 9 章：公司簡介

  • Amcor plc
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Gerresheimer AG
  • SCHOTT Pharma
  • Becton, Dickinson, and Company
  • DS Smith
  • Berry Global Inc.
  • Smurfit Kappa
  • Sanner GmbH
  • Avient Corporation
  • Bormioli Pharma SpA

第 10 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 11 章：附錄

簡介目錄
Product Code: OT8933

The global bio based packaging market reached US$ 1.9 billion in 2024 and is expected to reach US$ 4.0 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

Healthcare bio-based packaging refers to packaging solutions specifically designed for the pharmaceutical, medical device, and healthcare industries that are made from renewable, biologically sourced materials rather than conventional plastics or other non-biodegradable materials. These packaging solutions are developed to meet the stringent requirements of the healthcare sector, such as sterility, barrier protection, durability, and safety, while also being environmentally friendly.

The demand for bio-based packaging in the healthcare sector has been growing steadily as healthcare companies and consumers alike recognize the importance of sustainability and reducing the environmental impact of packaging materials. For instance, according to the Association of the British Pharmaceutical Industry (ABPI), about 70 to 80% of the carbon footprint sits in the manufacturing process and as the designers and inventors of those manufacturing processes say the decisions made will live with that product for the rest of its useful life as a medicine.

Market Dynamics: Drivers & Restraints

Rising sustainability goals of pharmaceutical companies

The rising sustainability goals of pharmaceutical companies are significantly driving the growth of the bio based packaging market and are expected to drive the market over the forecast period. Major pharmaceutical companies are setting ambitious sustainability targets, such as achieving net-zero emissions or reducing their carbon footprint by integrating sustainability into their corporate strategies by using bio-based packaging materials to meet these goals.

For instance, in October 2024, TekniPlex Healthcare unveiled the first ISCC PLUS-certified bio-based PVC compounds, offering a sustainable alternative for medical packaging. Its new materials are designed for use in medical packaging applications like tubing, films for trays, pouches, and other plastic components, providing eco-friendly options. Made with renewable energy, its compounds reduce CO2 emissions by up to 90%, helping the healthcare industry create more sustainable packaging without losing performance or safety.

Regulatory bodies, such as the FDA and EMA, are increasingly focused on reducing the environmental impact of packaging materials in the healthcare sector. These regulations encourage the adoption of sustainable practices, including the use of bio-based packaging materials by obtaining certifications like ISO compliance.

For instance, in January 2024, Avient Corporation, a leading provider of specialized and sustainable material solutions and services, announced it is highlighting its portfolio of bio-based polymer solutions at Pharmapack 2024. These solutions include bio-based polymer colorants and additives and bio-derived thermoplastic elastomers with lower product carbon footprint (PCF) values substantiated by Avient's PCF Calculator certified by TUV Rheinland for ISO 14067 compliance.

Stringent regulatory requirements

Stringent regulatory requirements significantly hamper the growth of the bio-based packaging market by creating barriers that complicate compliance, increase costs and limit market adoption. These regulations are particularly stringent in the healthcare sector due to the critical nature of pharmaceutical packaging. Bio-based packaging must meet the same rigorous standards as traditional materials for safety, sterility, and functionality in pharmaceutical applications. This includes rigorous biocompatibility tests, stability tests, and compatibility with the drug or medical device within the packaging.

For instance, the FDA requires bio-based packaging materials to undergo extensive testing to demonstrate that they do not interact negatively with the contents, such as pharmaceuticals or medical devices. Like, materials must not leach harmful substances or compromise the integrity of the drug or device. These requirements make the regulatory process more complex and time-consuming for bio-based materials compared to traditional plastics.

The regulatory requirements for bio-based materials vary significantly across different regions, creating challenges for companies looking to market their products globally. For instance, the FDA in the U.S. has different regulations compared to the EU's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations. These differences complicate the ability of bio-based packaging manufacturers to standardize their products for international markets.

Segment Analysis

The global bio based packaging market is segmented based on material type, application and region.

Material Type:

The biodegradable plastics segment is expected to dominate the bio based packaging market share

Biodegradable plastics are derived from renewable resources like corn starch, sugarcane, or polylactic acid (PLA). These materials can break down more easily in natural environments, reducing the overall environmental footprint compared to conventional plastics, which can persist for hundreds of years in landfills. Biodegradable plastics can be engineered to have similar properties to traditional plastics, such as durability, moisture resistance, and chemical resistance, making them suitable for packaging pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Rising investments in biodegradable plastics are also increasing the market demand. For instance, in September 2024, Darmstadt-based BIOVOX announced the successful closing of its €2.2 million seed round. The round was led by High-Tech Grunderfonds (HTGF) with significant participation from Beteiligungs-Managementgesellschaft Hessen mbH (BMH) and a group of existing and new investors including Auxxo, Otto Braun, Petra Worwag and Katharina Klohe as well members of the business angel club better ventures and Business Angels FrankfurtRheinMain. The investment will enable BIOVOX to accelerate the development and production of its portfolio of innovative bioplastic solutions designed to revolutionize the healthcare industry.

Geographical Analysis

North America is expected to hold a significant position in the bio based packaging market share

North America, particularly the United States and Canada, has a strong regulatory framework that encourages the adoption of sustainable packaging materials in the healthcare sector. The US FDA and Canadian regulatory bodies are pushing for more sustainable solutions to reduce the environmental impact of pharmaceutical packaging.

For instance, the FDA has issued guidance on the use of environmentally friendly packaging materials, including bio-based plastics, to ensure the safety and efficacy of pharmaceuticals. The directive is aimed at promoting packaging that is not only effective in protecting products but also sustainable.

In North America, there is a growing consumer preference for environmentally friendly products, which influences pharmaceutical companies to seek sustainable packaging solutions. Consumers are becoming more aware of the environmental impact of packaging materials and are demanding more eco-friendly options. This trend is particularly strong among younger demographics, who are more likely to choose sustainable products. For instance, according to the survey conducted by Accenture found that 83% of US consumers believe it's important for companies to design products that are environmentally friendly.

Asia-Pacific is growing at the fastest pace in the bio based packaging market

The Asia-Pacific region is witnessing significant economic growth, especially in countries like China, India, and Japan. This economic development is leading to an increased demand for healthcare products, which in turn drives the need for sustainable packaging solutions. As disposable incomes rise and urbanization accelerates, consumers are becoming more aware of the environmental impact of packaging and are increasingly demanding eco-friendly alternatives.

For instance, in China, the healthcare packaging market is expanding rapidly due to an aging population and increased healthcare spending. This growth is prompting the adoption of bio-based packaging to meet the demands of the pharmaceutical industry, which is under pressure to reduce waste and comply with stricter environmental regulations.

Major pharmaceutical companies in the APAC region are setting ambitious sustainability targets and are actively seeking bio-based packaging solutions to meet these goals. For example, companies like Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma in India are increasingly using bio-based packaging materials to meet global standards and enhance their sustainability profiles.

Competitive Landscape

The major global players in the bio based packaging market include Amcor plc, Gerresheimer AG, SCHOTT Pharma, Becton, Dickinson, and Company, DS Smith, Berry Global Inc., Smurfit Kappa, Sanner GmbH, Avient Corporation, Bormioli Pharma S.p.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global bio based packaging market report delivers a detailed analysis with 54 key tables, more than 44 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Material Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising sustainability goals of pharmaceutical companies
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent regulatory requirements
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Bio Based Packaging Market, By Material Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 5.1.2. Market Attractiveness Index, By Material Type
  • 5.2. Biodegradable Plastics*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Biodegradable Paper and Paperboard
  • 5.4. Biodegradable Films
  • 5.5. Others

6. Bio Based Packaging Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Pharmaceutical & Biopharmaceutical Industries*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Nutraceutical Companies
  • 6.4. Personal Care and Cosmetics
  • 6.5. Others

7. Bio Based Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Amcor plc*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Gerresheimer AG
  • 9.3. SCHOTT Pharma
  • 9.4. Becton, Dickinson, and Company
  • 9.5. DS Smith
  • 9.6. Berry Global Inc.
  • 9.7. Smurfit Kappa
  • 9.8. Sanner GmbH
  • 9.9. Avient Corporation
  • 9.10. Bormioli Pharma S.p.A.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us